Health ❯ Healthcare ❯ Clinical Research

Drug Development

Clinical Trials Phase 3 Trials Eli Lilly Lecanemab Comparative Effectiveness Therapeutics Antiviral Research Alzheimer's Treatments Antimicrobial Resistance Strategies GSK Innovations LENZ Therapeutics Therapeutic Innovations Antibody-Drug Conjugates (ADCs) Teplizumab Trials Biologic Drugs Phase 2 Trials Orforglipron Pediatric Medicine Alzheimer's Disease Therapies Immunotherapy Trials Efficacy Studies Antiviral Candidates

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Failure to convert higher progranulin levels into slowed FTD progression is prompting a shift of resources to other trials.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2025 Mina Labs Inc.